Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients

Thyroid

Volumn 15, Issue 10, 2005, Pages 1125-1130

  Ramos Lopez, Elizabeth ^a   Kurylowicz, Alina ^b   Bednarczuk, Tomasz ^b   Paunkovic, Jane ^c   Seidl, Christian ^d   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c Medical Center Zajecar   (Serbia)

^d Institute of Transfusion Medicine and Immunohaematology   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ADULT; AGED; APAI GENE; ARTICLE; BSMI GENE; CONTROLLED STUDY; FEMALE; FOKI GENE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; GRAVES DISEASE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TAQI GENE; YUGOSLAVIA;

EID: 28344444764     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1125     Document Type: Article

References (29)

1. Simmonds MJ, Gough SC 2004 Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond. Clin Exp Immunol 136:1-10.
2. Badenhoop K, Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112-2117.
3. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Hewlett S, Healy B, Nutland S, Ranee HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, lonescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 29:506-511.
4. Furugaki K, Shirasawa S, Ishikawa N, Ito K, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T 2004 Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet 49:166-168.
5. Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10:475-480.
6. Ban Y, Taniyama M, Ban Y 2000 Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 85:4639-4643.
7. Miyamoto K, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, Inoue Y, Morita K, Takeda E, Pike JW 1997 Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11:1165-1179.
8. Strugnell SA, DeLuca HF 1997 The Vitamin D receptor structure and transcriptional activation. Proc Soc Exp Biol Med 215:223-228.
9. Walters MR 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764.
10. Cippitelli M, Santoni A 1998 Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur J Immunol 28:3017-3030.
11. Fournier C, Gepner P, Sadouk M, Charrèire J 1990 In vivo beneficial effects of cyclosporin A and 1.25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 54:53-63.
12. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R 1994 Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D. Diabetologia 37:552-558.
13. Lemire JM, Archer DC 1991 1.25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87:1103-1107.
14. McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha C, Hitman GA 1997 Allelic Variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 40:971-975.
15. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, Badenhoop K 2000 Vitamin D receptor allele combination influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 49:504-507.
16. Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC 2004 Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin Endocrinol 60:618-624.
17. Nejentsev S, Cooper JD, Godfrey L, Howson JM, Ranee H, Nutland S, Walker NM, Guja C, Ionescu-Tirgoviste C, Savage DA, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Gillespie KM, Ring SM, Strachan DP, Widmer B, Dunger D, Todd JA 2004 Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes 53:2709-2712.
18. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D 1996 The presence of a polymorphism at the trans-lation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11:1850-1855.
19. Pani MA, Seissler J, Usadel KH, Badenhoop K 2002 Vitamin D receptor genotype is associated with Addison's disease. Eur J Endocrinol 147:635-640.
20. Raby BA, Lazarus R, Silverman EK, Lake S, Lange C, Wjst M, Weiss ST 2004 Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med 169:214-219.
21. McClure L, Eccleshall TR, Gross C, Villa ML, Lin N, Ramaswamy V, Kohlmeier L, Kelsey JL, Marcus R, Feldman D 1997 Vitamin D receptor polymorphisms, bone mineral density and bone metabolism in postmenopausal Mexican-American women. J Bone Miner Res 12:234-240.
22. 3 suppress human T/helper/inducer lymphocyte activity in vitro. J Immunol 134:3032-3035.
23. Correa P, Akerstrom G, Westin G 2002 Exclusive underexpression of vitamin D receptor exon If transcripts in tumors of primary hyperparathyroidism. Eur J Endocrinol 147:671-675.
24. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR 2000 The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14:401-420.
25. van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO 2004 1alpha.25-Dihydroxyvitamin D(3) or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23:233-239.
26. Mahon BD, Wittke A, Weaver V, Cantorna MT 2003 The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922-932.
27. Marti G, Audi L, Esteban C, Oyarzibal M, Chueca M, Gussine M, Yeste D, Fernandez-Cancio M, Andaluz P, Carrascosa A 2004 Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus in two Spanish populations. Med Clin 123:286-290.
28. Turpeinen H, Hermann R, Vaara S, Laine AP, Simell O, Knip M, Veijola R, Ilonen J 2003 Vitamin D receptor polymorphisms: No association with type 1 diabetes in the Finnish population. Eur J Endocrinol 149:591-596.
29. Laaksonen MM, Karkkainen MU, Outila TA, Rita HJ, Lamberg-Allardt CJ 2004 Vitamin D receptor gene start codon polymorphism (FokI) is associated with forearm bone mineral density and calcaneal ultrasound in Finnish adolescent boys but not in girls. J Bone Miner Res 22:479-485.